Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/sol-trades-expected-to-lose-200-m-if-this-happens-why-rblk-has-already-started-february-on-a-bullish-trend/